- Home
- SNTI vs GMM Comparison
SNTI vs GMM Comparison
Compare SNTI & GMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- GMM
- Stock Information
- Founded
- SNTI 2016
- GMM 2017
- Country
- SNTI United States
- GMM China
- Employees
- SNTI N/A
- GMM N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- GMM
- Sector
- SNTI Health Care
- GMM
- Exchange
- SNTI Nasdaq
- GMM Nasdaq
- Market Cap
- SNTI 53.6M
- GMM 57.9M
- IPO Year
- SNTI N/A
- GMM 2023
- Fundamental
- Price
- SNTI $2.05
- GMM $1.59
- Analyst Decision
- SNTI Strong Buy
- GMM
- Analyst Count
- SNTI 4
- GMM 0
- Target Price
- SNTI $8.75
- GMM N/A
- AVG Volume (30 Days)
- SNTI 97.8K
- GMM 17.7K
- Earning Date
- SNTI 11-13-2025
- GMM 08-18-2025
- Dividend Yield
- SNTI N/A
- GMM N/A
- EPS Growth
- SNTI N/A
- GMM N/A
- EPS
- SNTI N/A
- GMM 1.79
- Revenue
- SNTI N/A
- GMM $48,171,048.00
- Revenue This Year
- SNTI N/A
- GMM N/A
- Revenue Next Year
- SNTI $150.00
- GMM N/A
- P/E Ratio
- SNTI N/A
- GMM $0.91
- Revenue Growth
- SNTI N/A
- GMM 41.74
- 52 Week Low
- SNTI $1.26
- GMM $1.41
- 52 Week High
- SNTI $16.94
- GMM $4.97
- Technical
- Relative Strength Index (RSI)
- SNTI 56.53
- GMM 32.52
- Support Level
- SNTI $1.44
- GMM $1.41
- Resistance Level
- SNTI $2.16
- GMM $1.62
- Average True Range (ATR)
- SNTI 0.18
- GMM 0.09
- MACD
- SNTI 0.02
- GMM -0.01
- Stochastic Oscillator
- SNTI 84.03
- GMM 30.42
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About GMM Global Mofy Metaverse Limited
Global Mofy AI Ltd operates as a technology solutions provider engaged in virtual content production, digital marketing, and digital assets development for the metaverse industry. It utilizes its proprietary Mofy Lab technology platform which consists of three-dimensional (3D) rebuilt technology and artificial intelligence (AI) interactive technology to create a 3D high-definition virtual version of a wide range of physical world objects such as human, animal, and scenes which can be used in different applications.